Sign In
Buy DGX
$233.72
+1.77 (+0.763%)
At Close: Aug 04, 2026
Molina Healthcare (MOH) to Get New Medicaid Contract in Iowa
03:40pm, Thursday, 01'st Sep 2022 Zacks Investment Research
Molina Healthcare's (MOH) Iowa health plan is likely to commence on Jul 1 next year.
Are Investors Undervaluing Quest Diagnostics (DGX) Right Now?
01:40pm, Thursday, 01'st Sep 2022 Zacks Investment Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Are Investors Undervaluing Quest Diagnostics (DGX) Right Now?
10:49am, Thursday, 01'st Sep 2022
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Encompass (EHC) Opens Its 4th Inpatient Rehab Unit in Illinois
05:34pm, Wednesday, 24'th Aug 2022 Zacks Investment Research
Encompass Health's (EHC) Quad Cities Rehabilitation Institute has 40 beds and serves patients who are recovering from enervating and complex illnesses and injuries.
3 Top Monkeypox Stocks to Buy Right Now
11:40am, Wednesday, 24'th Aug 2022
With the latest outbreak now reported in all 50 states per ABC News, investors may want to consider the top monkeypox stocks to buy right now. From an investment perspective, this latest health threat
Quest Diagnostics' (DGX) Base Volume Revives, New Ruling Aids
12:06pm, Wednesday, 17'th Aug 2022 Zacks Investment Research
With a bullish expectation for the remainder of 2022, Quest Diagnostics (DGX) raises its full-year guidance.
Quest Diagnostics' (DGX) Base Volume Revives, New Ruling Aids
09:47am, Wednesday, 17'th Aug 2022
With a bullish expectation for the remainder of 2022, Quest Diagnostics (DGX) raises its full-year guidance.
Illumina (ILMN) Q2 Earnings Miss Estimates, Slashes '22 View
01:34pm, Monday, 15'th Aug 2022 Zacks Investment Research
Robust sales contribution across operating segments drove Illumina's (ILMN) Q2 top line.
National Vision (EYE) Q2 Earnings Top Mark, Revenue View Cut
11:11am, Monday, 15'th Aug 2022 Zacks Investment Research
National Vision (EYE) is simultaneously facing demand headwinds across its network of stores, given the current macro environment, as well as supply challenges.
10 defensive stocks that can also provide you with growth and dividends over the long term
01:34pm, Saturday, 13'th Aug 2022 MarketWatch
Professional money managers have a strong preference for one stock sector in particular, along with cash dividends.
ResMed (RMD) Q4 Earnings Beat Estimates, Gross Margin Up
07:34pm, Friday, 12'th Aug 2022 Zacks Investment Research
ResMed (RMD) posts better-than-expected Q4 results with continued strength in sleep and respiratory care devices sales performance.
STERIS (STE) Gains From Cantel Buyout, Supply Chain Issue Stays
02:05pm, Friday, 12'th Aug 2022 Zacks Investment Research
Revenue growth at STERIS' (STE) Applied Sterilization Technologies is driven by increased demand from medical device and biopharma customers.
Illumina stock tanks as gene-sequencing company misses expectations and issues bleak outlook
01:32am, Friday, 12'th Aug 2022 MarketWatch
Illumina Inc. shares sank 17% after hours Thursday after the gene-sequencing company swung to a loss in the second quarter, fell short of revenue expectations and revised its full-year outlook downwar
Haemonetics (HAE) Q1 Earnings Beat Estimates, Margins Up
06:10pm, Thursday, 11'th Aug 2022 Zacks Investment Research
Haemonetics (HAE) posts better-than-expected results in Q1 with robust contributions from the Hospital business.
Accuray (ARAY) Q4 Earnings Beat Estimates, Margins Down
05:13pm, Thursday, 11'th Aug 2022 Zacks Investment Research
Despite solid Product revenues, Accuray (ARAY) reports an overall soft Q4 performance.
